Pharma News - Chemdiv

Roche, Repare Ink $1.2B Deal for Development of Cancer Therapy

Shares of Repare Therapeutics are soaring more than 27% in premarket trading following the announcement Wednesday of a global cancer collaboration valued at up to $1.2 billion with Swiss pharma gi...

FDA grants Fast Track Designation to mocravimod with HSCT for acute myeloid leukemia

The FDA granted fast track designation to mocravimod in combination with allogeneic hematopoietic stem cell transplantation for post-remission therapy of acute myeloid leukemia. ...

US FDA grants fast track designation to Midatech Pharma’s MTX110 to treat recurrent glioblastoma

Midatech Pharma PLC, an R&D biotechnology company, announced that upon submitting an application to the US Food and Drug Administration (FDA), its development programme of MTX110 for the treatm...

NICE Recommends UCB’s Fintepla for Dravet Syndrome-Related Seizures

The UK’s National Institute for Healthcare Excellence (NICE) has recommended UCB’s Fintepla (fenfluramine) for National Health Service (NHS) use in patients with Dravet syndrome-associated seiz...

Chemical inhibitor blocks final path to cell death in mice with Parkinson's symptoms

In studies in mice, Johns Hopkins Medicine researchers say they have identified a chemical compound that stops the final events in the pathway linked to the death of brain cells in Parkinson's dise...

Astellas’ subsidiary, Xyphos & GO Therapeutics ink research and license agreement to develop novel antibodies for immuno-oncology

Astellas Pharma Inc. and GO Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, Xyphos) and GO have entered into a strategic research collaboration a...

WHO says monkeypox has been spreading undetected as global cases rise to more than 550

The World Health Organization on Wednesday confirmed more than 550 monkeypox cases across 30 countries as the virus continues to spread across the globe.

FDA Pulls Approval for TG Therapeutics' Cancer Drug

Shares of TG Therapeutics are falling fast in Wednesday trading after the U.S. Food and Drug Administration announced it was pulling approval of the cancer drug Ukoniq (umbralisib).

Pfizer to Sell Stake in Haleon Following GSK De-Merger

Next month, GlaxoSmithKline will complete its de-merger, forming two companies, New GSK, a pharma-focused business, and Haleon, a stand-alone consumer health operation.

With $600M in Funding, Ultima is Removing Cost Barriers to Genomic Research

How much could a human genome cost? The answer is $100, according to newly unveiled biotech company Ultima Genomics.

BMS Preps Lupus Treatment to Become Third New Launch of 2022

Bristol Myers Squibb (BMS) has announced late-breaking data showing deucravacitinib significant efficacy at the primary endpoint for the treatment of systemic lupus erythematosus (SLE). ...

Britain’s GSK to buy Affinivax for up to $3.3 billion in vaccines push

GSK said today it would pay up to $3.3 billion to acquire privately held biopharma firm Affinivax to bolster its vaccine pipeline, a key area of focus as the British drugmaker prepares to separate ...